Cargando…
Biomarkers to assess the risk of bladder cancer in patients presenting with haematuria are gender-specific
INTRODUCTION: Haematuria is a common red flag symptom of urinary tract cancer. Bladder cancer (BC) is the most common cancer to present with haematuria. Women presenting with haematuria are often underdiagnosed. Currently, no gender-specific tests are utilized in clinical practice. Considerable heal...
Autores principales: | Duggan, Brian, O’Rourke, Declan, Anderson, Neil, Reid, Cherith N., Watt, Joanne, O’Kane, Hugh, Boyd, Ruth, Curry, David, Evans, Mark, Stevenson, Michael, Kurth, Mary Jo, Lamont, John V., Fitzgerald, Peter, Ruddock, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539269/ https://www.ncbi.nlm.nih.gov/pubmed/36212463 http://dx.doi.org/10.3389/fonc.2022.1009014 |
Ejemplares similares
-
Clinical features and predictive biomarkers for bladder cancer in patients with type 2 diabetes presenting with haematuria
por: Tonry, Claire L., et al.
Publicado: (2022) -
An early analysis of the cost-effectiveness of a diagnostic classifier for risk stratification of haematuria patients (DCRSHP) compared to flexible cystoscopy in the diagnosis of bladder cancer
por: Sutton, Andrew J., et al.
Publicado: (2018) -
Non-alcoholic fatty liver disease—A pilot study investigating early inflammatory and fibrotic biomarkers of NAFLD with alcoholic liver disease
por: Watt, Joanne, et al.
Publicado: (2022) -
Thrombomodulin Expression in Bladder Cancer Tissue and Its Association with Prognosis and Patient Survival
por: Watt, Joanne, et al.
Publicado: (2020) -
Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data
por: Emmert-Streib, Frank, et al.
Publicado: (2013)